Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations
Pharmacoepidemiology and Drug Safety2011Vol. 20(6), pp. 626–634
Citations Over TimeTop 10% of 2011 papers
Dominik Rottenkolber, Sven Schmiedl, Marietta Rottenkolber, Katrin Farker, Karen Saljé, Silke Mueller, Marion Hippius, Petra Thuermann, Joerg Hasford
Abstract
Preventing ADRs is advisable in order to realize significant nationwide savings potential. Our cost estimates provide a reliable benchmark as they were calculated based on an intensified ADR surveillance and an accurate person-related cost application.
Related Papers
- ADVERSE DRUG REACTION (ADR) MONITORING AND PHARMACOVIGILANCE(2010)
- Kerman Health System Workers Knowledge and Attitudes Regarding the Spontaneous Reporting System for Adverse Drug Reactions(2009)
- The Distinction of Pharmacovigilance with Adverse Drug Reaction Monitoring(2006)
- Evaluation of knowledge, attitude and perception of healthcare professionals towards pharmacovigilance and (Adverse Drug Reaction reporting) ADR reporting in South India(2014)
- Assessment of Knowledge, Attitude and Practice ofPharmacovigilance and Adverse Drug Reaction Reporting among Nursing Staff(2018)